The Biden administration is unlikely to see its long-delayed Food and Drug Administration (FDA) director confirmed before the end of the year, despite fears of a new coronavirus variant and a winter surge, thanks to an avoidable paperwork blunder.
Politico reported on Tuesday:
A plan to speed Robert Califf’s nomination for FDA commissioner through the Senate next month is on hold after the Biden administration failed to submit the necessary paperwork to Congress in time, three people with knowledge of the matter told POLITICO.
The delay means that Califf is now unlikely to get a…
